Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Experimental & Clinical Cancer Research : CR|June 7, 2000
Decline of met-enkephalins concentration after interleukin-2 subcutaneous administration due to renal carcinomaB Zubelewicz, R Braczkowski, W Romanowski, et al.Polskie Archiwum Medycyny Wewnetrznej|December 1, 1995
[Influence of treatment using recombinant tumor necrosis factor alpha (hrec TNF alpha) on circadian rhythm of cortisol secretion in patients with advanced neoplastic disease]B Zubelewicz, R Braczkowski, W Romanowski, et al.Ortopedia, Traumatologia, Rehabilitacja|November 7, 2007
Procedure for rehabilitation of the knee following synovectomy in patients with rheumatoid arthritis at the Poznań Rheumatological Center in SremaZ Brenda, W Romanowski, P Bieńkowski, et al.Journal of Experimental & Clinical Cancer Research : CR|January 23, 1999
Possible biological indicators of the response to recombinant tumour necrosis factor alpha in patients with advanced neoplasmsR Braczkowski, B Zubelewicz, W Romanowski, et al.Journal of Experimental & Clinical Cancer Research : CR|March 24, 1999
Transient increase of plasma interleukin-6 after infusion of recombinant tumor necrosis factor alpha in advanced cancer patientsB Zubelewicz, W Romanowski, B Braczkowska, et al.Journal of Experimental & Clinical Cancer Research : CR|January 23, 1999
Genetic testing for breast cancer susceptibility: Polish women's attitudesR Braczkowski, E Nowakowska-Zajdel, B Zubelewicz, et al.Journal of Biological Regulators and Homeostatic Agents|July 1, 1994
Preliminary study on modulation of the biological effects of tumor necrosis factor-alpha in advanced cancer patients by the pineal hormone melatoninR Brackowski, B Zubelewicz, W Romanowski, et al.Journal of Biological Regulators and Homeostatic Agents|July 30, 2002
Genetic disregulation of gene coding tumor necrosis factor alpha receptors (TNF alpha Rs) in follicular thyroid cancer--preliminary reportB Zubelewicz, M Muc-Wierzgoń, J Wierzgoń, et al.Journal of Biological Regulators and Homeostatic Agents|March 25, 2005
Simvastatin decreases concentration of interleukin-2 in hypercholesterolemic patients after treatment for 12 weeksB Zubelewicz-Szkodzińska, J Szkodziński, W Romanowski, et al.Journal of Biological Regulators and Homeostatic Agents|May 22, 2010
Serum concentration of insulin-like growth factor-I, but not tumor necrosis factor-alpha, measured twelve months after stenting of the infarct-related artery, is associated with in-stent restenosisJanusz Szkodzinski, B Hudzik, W Romanowski, et al.Pageof 2